The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies

J. Nagy, G. Bajtai, H. Brasch, T. Süle, M. Ambrus, G. Deák, A. Hámori

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The frequency of hepatitis B surface antigen (HBsAg) has been studied in the sera and renal biopsies of 276 patients with various forms of glomerulonephritis (GN), the nephrotic syndrome and other nephropathies. Using a modified Hepanosticon method, HBs antigenemia was detected in 32 of 196 patients (16.3%) with immune complex (IC) GN and the nephrotic syndrome. Indirect immunofluorescence revealed HBsAg in 33 renal biopsy tissue specimens (16.8%). HBsAg was found in the sera of four of the 80 remaining patients with other renal diseases (5%), and in the renal biopsy tissues of another four (5%). Antibody against HBsAg could only be demonstrated in the serum of one glomerulonephritic patient. The sera of 18,799 normal blood donors were used as controls; of these 186 (0.99%) had positive tests for HBsAg. It is concluded that, in some patients with GN and the nephrotic syndrome, HBsAg-containing IC may be implicated in the development and/or progression of the disease.

Original languageEnglish
Pages (from-to)109-116
Number of pages8
JournalClinical Nephrology
Volume12
Issue number3
Publication statusPublished - 1979

Fingerprint

Hepatitis B Surface Antigens
Nephrotic Syndrome
Glomerulonephritis
Kidney
Antigen-Antibody Complex
Serum
Biopsy
Indirect Fluorescent Antibody Technique
Blood Donors
Disease Progression
Antibodies

ASJC Scopus subject areas

  • Nephrology

Cite this

Nagy, J., Bajtai, G., Brasch, H., Süle, T., Ambrus, M., Deák, G., & Hámori, A. (1979). The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clinical Nephrology, 12(3), 109-116.

The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. / Nagy, J.; Bajtai, G.; Brasch, H.; Süle, T.; Ambrus, M.; Deák, G.; Hámori, A.

In: Clinical Nephrology, Vol. 12, No. 3, 1979, p. 109-116.

Research output: Contribution to journalArticle

Nagy, J, Bajtai, G, Brasch, H, Süle, T, Ambrus, M, Deák, G & Hámori, A 1979, 'The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies', Clinical Nephrology, vol. 12, no. 3, pp. 109-116.
Nagy J, Bajtai G, Brasch H, Süle T, Ambrus M, Deák G et al. The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. Clinical Nephrology. 1979;12(3):109-116.
Nagy, J. ; Bajtai, G. ; Brasch, H. ; Süle, T. ; Ambrus, M. ; Deák, G. ; Hámori, A. / The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies. In: Clinical Nephrology. 1979 ; Vol. 12, No. 3. pp. 109-116.
@article{309ed50080f049f0888d90e09fbd4799,
title = "The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies",
abstract = "The frequency of hepatitis B surface antigen (HBsAg) has been studied in the sera and renal biopsies of 276 patients with various forms of glomerulonephritis (GN), the nephrotic syndrome and other nephropathies. Using a modified Hepanosticon method, HBs antigenemia was detected in 32 of 196 patients (16.3{\%}) with immune complex (IC) GN and the nephrotic syndrome. Indirect immunofluorescence revealed HBsAg in 33 renal biopsy tissue specimens (16.8{\%}). HBsAg was found in the sera of four of the 80 remaining patients with other renal diseases (5{\%}), and in the renal biopsy tissues of another four (5{\%}). Antibody against HBsAg could only be demonstrated in the serum of one glomerulonephritic patient. The sera of 18,799 normal blood donors were used as controls; of these 186 (0.99{\%}) had positive tests for HBsAg. It is concluded that, in some patients with GN and the nephrotic syndrome, HBsAg-containing IC may be implicated in the development and/or progression of the disease.",
author = "J. Nagy and G. Bajtai and H. Brasch and T. S{\"u}le and M. Ambrus and G. De{\'a}k and A. H{\'a}mori",
year = "1979",
language = "English",
volume = "12",
pages = "109--116",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "3",

}

TY - JOUR

T1 - The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies

AU - Nagy, J.

AU - Bajtai, G.

AU - Brasch, H.

AU - Süle, T.

AU - Ambrus, M.

AU - Deák, G.

AU - Hámori, A.

PY - 1979

Y1 - 1979

N2 - The frequency of hepatitis B surface antigen (HBsAg) has been studied in the sera and renal biopsies of 276 patients with various forms of glomerulonephritis (GN), the nephrotic syndrome and other nephropathies. Using a modified Hepanosticon method, HBs antigenemia was detected in 32 of 196 patients (16.3%) with immune complex (IC) GN and the nephrotic syndrome. Indirect immunofluorescence revealed HBsAg in 33 renal biopsy tissue specimens (16.8%). HBsAg was found in the sera of four of the 80 remaining patients with other renal diseases (5%), and in the renal biopsy tissues of another four (5%). Antibody against HBsAg could only be demonstrated in the serum of one glomerulonephritic patient. The sera of 18,799 normal blood donors were used as controls; of these 186 (0.99%) had positive tests for HBsAg. It is concluded that, in some patients with GN and the nephrotic syndrome, HBsAg-containing IC may be implicated in the development and/or progression of the disease.

AB - The frequency of hepatitis B surface antigen (HBsAg) has been studied in the sera and renal biopsies of 276 patients with various forms of glomerulonephritis (GN), the nephrotic syndrome and other nephropathies. Using a modified Hepanosticon method, HBs antigenemia was detected in 32 of 196 patients (16.3%) with immune complex (IC) GN and the nephrotic syndrome. Indirect immunofluorescence revealed HBsAg in 33 renal biopsy tissue specimens (16.8%). HBsAg was found in the sera of four of the 80 remaining patients with other renal diseases (5%), and in the renal biopsy tissues of another four (5%). Antibody against HBsAg could only be demonstrated in the serum of one glomerulonephritic patient. The sera of 18,799 normal blood donors were used as controls; of these 186 (0.99%) had positive tests for HBsAg. It is concluded that, in some patients with GN and the nephrotic syndrome, HBsAg-containing IC may be implicated in the development and/or progression of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0018703606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018703606&partnerID=8YFLogxK

M3 - Article

C2 - 389501

AN - SCOPUS:0018703606

VL - 12

SP - 109

EP - 116

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 3

ER -